Skip to main
  1. Stocks
  2. CareTrust REIT
  3. Forecast
CTRE

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 55%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

CareTrust REIT is supported by a strong external growth engine, as it has repeatedly outperformed on normalized FFO and FAD while raising FY26 guidance to $2.08–$2.09 and $2.04–$2.05, respectively. Its $2.9B YTD investment pace at an 8.1% stabilized yield, plus a $1.2B actionable pipeline and recent equity and debt financing, point to ample capital to keep compounding cash flow. The outlook is further strengthened by low leverage, with reported net debt to annualized adjusted EBITDA of 1.4x, resilient triple-net lease economics, and a maintained $0.39 quarterly dividend with a 74.1% 3Q26 payout ratio.

Bears say

CareTrust REIT is exposed to a weak risk/reward setup because its earnings depend on careful acquisition underwriting in a highly regulated skilled nursing market where reimbursement, licensure, and labor conditions can quickly pressure operator cash flow and property NOI. The company also faces elevated tenant concentration risk, with Ensign representing a significant share of NOI and carrying lingering compliance overhang from the October 2013 corporate integrity agreement, while headline risk from PACS could still re-emerge. At the same time, competition for healthcare assets may inflate purchase prices and tighter debt or capital markets could constrain leverage-funded growth, undermining profitability and valuation.

CareTrust REIT (CTRE) has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 55% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

CareTrust REIT (CTRE) Analyst Forecast & Price Prediction

Get the latest CareTrust REIT (CTRE) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CareTrust REIT (CTRE)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 11 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


CareTrust REIT (CTRE) Analyst Forecast & Price Prediction

Get the latest CareTrust REIT (CTRE) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CareTrust REIT (CTRE)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CTRE stock data and trends